IL-6 as Therapeutic Target in Inflammation and CVD

April 2022

Publication: Physicians Academy of Cardiovascular Education

Source / Author: PACE - CME

Professor Ridker discusses the CANTOS trial and findings of studies on IL-6 and CV risk to look to the future.

View here

 

Read more

Cover photo for Caristo's Symposium at SCCT Symposium

February 2023

Author: Caristo Sponsored Symposium

The future of comprehensive cardiovascular risk prediction using CCTA | SCCT Edinburgh 2023

Dr. Nik Sabharwal, Prof. Ronak Rajani and Dr. Alain Tavildari discuss the future of cardiovascular risk prediction and inflammation as…

Read more

December 2022

Author: PACE - CME

Inflammation as a new target in CV risk reduction

“Lowering LCL-c is the first, second and third thing we have to do to lower atherosclerotic event rates, but what…